Human Microbiome Market is expected to reach US$ 2,921.68 Mn by 2028

Probiotics Products to Hold Largest Share of Human Microbiome Market During 2021–2028

According to our new research study on “Human Microbiome Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Disease, and Application,” the market is expected to reach US$ 2,921.68 million by 2028 from US$ 718.95 million in 2021; it is estimated to grow at a CAGR of 22.2% during 2021–2028. The report highlights trends prevailing in the market and factors driving its growth. The human microbiome market growth is mainly attributed to the factors such as increasing incidence of lifestyle diseases, rising focus on human microbiome therapies, and growing technological advancements in metagenomics and next-generation sequencing. However, strict government guidelines and the lack of knowledge about detailed examination hinder the market growth. 

Based on product, the human microbiome market is further segmented into probiotics, foods, prebiotics, medical foods, diagnostic device, drugs and supplements. The human microbiome market on the basis of products is segmented into probiotics, foods, prebiotics, medical foods, diagnostic devices, drugs, and supplements. The probiotics segment is expected to hold the largest market share of 24.71% in 2021. This segment is also expected to dominate the market in 2028, and increasing concerns regarding health; growing awareness about the relation between nutrition, diet, and health; and surging penetration of probiotics in dairy and other food & beverages industries would favor the overall demand in the coming years. Furthermore, the prebiotics segment is anticipated to register the highest CAGR in the human microbiome market during 2021–2028.

The human microbiome market, by disease, is segmented into diabetes, cancer, autoimmune disorders, obesity, mental disorders, and other diseases. Based on application, the market is segmented into diagnostics and therapeutics.

MaaT Pharma; ELIGO BIOSCIENCE; AOBiome; Kaleido Biosciences, Inc.; Seres Therapeutics; Merck & Co., Inc; Yakult Honsha Co., Ltd; Rebiotix, Inc.; DuPont de Nemours, Inc; and Synthetic Biologics, Inc. are among the leading companies operating in the human microbiome market.

Human Microbiome Market, by Region, 2021 (%)

---

Human Microbiome Market Size, Share | Report 2021, 2028

Download Free Sample

---

Human Microbiome Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others) and Application (Therapeutics and Diagnostics) and Geography

By Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East and Africa (MEA)
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East and Africa
• South and Central America (SCAM)
  • Brazil
  • Argentina
  • Rest of South and Central America